In July 2015, researchers announced that a vaccine trial in Guinea had been completed that appeared to give protection from the virus.
In December 2016, the results of the two-year Guinea trial were published announcing that rVSV-ZEBOV had been found to protect people who had been exposed to cases of Ebola [REF].